Trial Profile
Effects of Tinzaparin sodium on Cardio-vascular OUtcomes and on blood Lipids in Diabetic patients on Chronic HEmodialysis: a Long-term, Prospective study (The 'Tinzaparin COULD HELP' study)
Status:
Withdrawn prior to enrolment
Phase of Trial:
Phase IV
Latest Information Update: 29 Dec 2017
Price :
$35
*
At a glance
- Drugs Tinzaparin sodium (Primary) ; Heparin
- Indications Thrombosis
- Focus Pharmacodynamics
- Acronyms Tinzaparin COULD HELP
- 21 Dec 2017 Status changed from suspended to withdrawn prior to enrolment.
- 24 Jan 2017 Planned End Date changed from 1 Dec 2013 to 1 Jan 2017.
- 28 Jan 2013 Planned end date changed from 1 Dec 2011 to 1 Dec 2013 as reported by ClinicalTrials.gov.